MSD Animal Health (known as Merck Animal Health in the USA and Canada) today announced the launch of PORCEPTAL® as the newest addition to its REPROPIG® Management System in Europe. PORCEPTAL induces ovulation in pigs 30 to 33 hours after application, giving producers the ability to artificially inseminate batches of
sows at one predetermined time instead of doing multiple inseminations.
By timing and synchronizing ovulation, PORCEPTAL helps producers simplify their breeding schedule and reduce the amount of time their workforce spends on heat checks and inseminations. A single insemination also allows producers to purchase less semen, but from a smaller number of higher-quality boars, which results in litters that have greater genetic uniformity. In addition, PORCEPTAL reduces the time between weaning and insemination in
sows, meaning fewer non-productive days.
PORCEPTAL is the newest addition to MSD Animal Health’s reproduction health management platform REPROPIG, which also includes REGUMATE®, PG-600® and PLANATE®. PORCEPTAL is used alone in sows following weaning, but in gilts it follows a period of treatment with REGUMATE, which synchronizes estrus. In addition to this product portfolio, REPROPIG includes a web-based decision-making system that incorporates herd audits, economic data and performance results to provide customized recommendations and training to help producers meet their goals.
“MSD Animal Health is committed to providing producers with the products and services they need to manage their herds’ reproductive needs,” said Narciso Bento, MSD Animal Health. “We are pleased to announce the addition of PORCEPTAL to the REPROPIG portfolio to help producers maximize their reproductive efficiency while optimizing costs and simplifying their schedules.”
A multi-center, multi-genetic, randomized clinical trial in the EU demonstrated that PORCEPTAL achieved comparable reproductive performance in both sows and gilts, with a single artificial insemination, compared to a traditional breeding protocol with multiple heat detections and artificial inseminations, while providing all the benefits related with the reduced labor, less non-productive days and litter uniformity.
The active ingredient in PORCEPTAL is buserelin acetate, a synthetic gonadotropinreleasing hormone (GnRH) analogue that triggers the release of luteinizing hormone (LH), thereby inducing and synchronizing ovulation. PORCEPTAL is administered via intra-muscular or subcutaneous injection.
May 15, 2014 - MSD